BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37718459)

  • 1. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
    Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
    World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling.
    Zeng C; Lin J; Zhang K; Ou H; Shen K; Liu Q; Wei Z; Dong X; Zeng X; Zeng L; Wang W; Yao J
    Cancer Sci; 2022 Nov; 113(11):3766-3775. PubMed ID: 35968603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma.
    Yin Z; Liu Q; Gao Y; Wang R; Qi Y; Wang D; Chen L; Yin X; He M; Li W
    Mol Carcinog; 2024 May; 63(5):912-925. PubMed ID: 38390729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis.
    Wen LJ; Yin JG; Wang YX; Liu K; Zhao JX
    Parasit Vectors; 2023 Dec; 16(1):465. PubMed ID: 38124152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic Therapy Inhibits Cancer Progression and Induces Ferroptosis and Apoptosis by Targeting P53/GPX4/SLC7A11 Signaling Pathways in Cholangiocarcinoma.
    Yan X; Li Z; Chen H; Yang F; Tian Q; Zhang Y
    Photodiagnosis Photodyn Ther; 2024 Apr; ():104104. PubMed ID: 38679154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma.
    Zhang DY; Liu Z; Lu Z; Sun WL; Ma X; Zhang P; Wu BQ; Cui PY
    Onco Targets Ther; 2018; 11():7133-7142. PubMed ID: 30410369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircTMEM87A promotes the tumorigenesis of gastric cancer by regulating the miR-1276/SLC7A11 axis.
    Dong X; Chen X; Zhao Y; Wu Q; Ren Y
    J Gastroenterol Hepatol; 2024 Jan; 39(1):121-132. PubMed ID: 38037531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis.
    Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T
    Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma.
    Zhao W; Zhao J; Li K; Hu Y; Yang D; Tan B; Shi J
    Lab Invest; 2023 Sep; 103(9):100193. PubMed ID: 37285922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
    [No Abstract]   [Full Text] [Related]  

  • 14. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
    Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
    Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers.
    Xu Y; Leng K; Yao Y; Kang P; Liao G; Han Y; Shi G; Ji D; Huang P; Zheng W; Li Z; Li J; Huang L; Yu L; Zhou Y; Jiang X; Wang H; Li C; Su Z; Tai S; Zhong X; Wang Z; Cui Y
    Hepatology; 2021 Apr; 73(4):1419-1435. PubMed ID: 32750152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated
    Zeng J; Ma X; Wang J; Liu R; Shao Y; Hou Y; Li Z; Fang Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31101684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agrin expression is correlated with tumor development and poor prognosis in cholangiocarcinoma.
    He M; Cheng C; Tu J; Ji SS; Lou D; Bai B
    J Int Med Res; 2021 May; 49(5):3000605211009722. PubMed ID: 34018826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.